Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells
Glucose uptake in activated CD4+ T cells is essential for increased metabolic needs, synthesis of biomolecules and proliferation. Although, facilitated glucose transport is the predominant route for glucose entry at the time of activation, here we demonstrate role for the sodium-dependent glucose tr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576216/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850103478976774144 |
|---|---|
| author | Zhe Jin Hayma Hammoud Amol K. Bhandage Stasini Koreli Azazul Islam Chowdhury Peter Bergsten Bryndis Birnir |
| author_facet | Zhe Jin Hayma Hammoud Amol K. Bhandage Stasini Koreli Azazul Islam Chowdhury Peter Bergsten Bryndis Birnir |
| author_sort | Zhe Jin |
| collection | DOAJ |
| description | Glucose uptake in activated CD4+ T cells is essential for increased metabolic needs, synthesis of biomolecules and proliferation. Although, facilitated glucose transport is the predominant route for glucose entry at the time of activation, here we demonstrate role for the sodium-dependent glucose transporter SGLT2. By 72 h after activation, SGLT2 is expressed and functional in the human CD4+ T cells. SGLT2 inhibitors, phlorizin and empagliflozin decreased glucose uptake into the human CD4+ T cells compared to untreated cells. Phlorizin (25 μmol/L) reduced glycolysis at 5.6 mmol/L glucose and IFNγ levels at both 5.6 mmol/L and 16.7 mmol/L glucose. In contrast, empagliflozin (0.5 μmol/L) only decreased IFNγ levels in 16.7 mmol/L glucose. GABA enhanced phlorizin inhibition at both 5.6 mmol/L and 16.7 mmol/L glucose in the presence of insulin. Insulin strengthens GABAA receptors signaling in CD4+ T cells. The results are consistent with expression of SGLT2 after activation of human CD4+ T cells, that facilitates concentrating glucose uptake into the cells, enabling enhanced release of inflammatory molecules like IFNγ. Importantly, inhibition of SGLT2 decreases IFNγ release. |
| format | Article |
| id | doaj-art-8f5cba2773bf430e9e8008e8b6dab629 |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-8f5cba2773bf430e9e8008e8b6dab6292025-08-20T02:39:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.15762161576216Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cellsZhe JinHayma HammoudAmol K. BhandageStasini KoreliAzazul Islam ChowdhuryPeter BergstenBryndis BirnirGlucose uptake in activated CD4+ T cells is essential for increased metabolic needs, synthesis of biomolecules and proliferation. Although, facilitated glucose transport is the predominant route for glucose entry at the time of activation, here we demonstrate role for the sodium-dependent glucose transporter SGLT2. By 72 h after activation, SGLT2 is expressed and functional in the human CD4+ T cells. SGLT2 inhibitors, phlorizin and empagliflozin decreased glucose uptake into the human CD4+ T cells compared to untreated cells. Phlorizin (25 μmol/L) reduced glycolysis at 5.6 mmol/L glucose and IFNγ levels at both 5.6 mmol/L and 16.7 mmol/L glucose. In contrast, empagliflozin (0.5 μmol/L) only decreased IFNγ levels in 16.7 mmol/L glucose. GABA enhanced phlorizin inhibition at both 5.6 mmol/L and 16.7 mmol/L glucose in the presence of insulin. Insulin strengthens GABAA receptors signaling in CD4+ T cells. The results are consistent with expression of SGLT2 after activation of human CD4+ T cells, that facilitates concentrating glucose uptake into the cells, enabling enhanced release of inflammatory molecules like IFNγ. Importantly, inhibition of SGLT2 decreases IFNγ release.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576216/fullglucose uptakeT cellsSGLT2GLUT1immunomodulationIFNγ |
| spellingShingle | Zhe Jin Hayma Hammoud Amol K. Bhandage Stasini Koreli Azazul Islam Chowdhury Peter Bergsten Bryndis Birnir Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells Frontiers in Immunology glucose uptake T cells SGLT2 GLUT1 immunomodulation IFNγ |
| title | Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells |
| title_full | Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells |
| title_fullStr | Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells |
| title_full_unstemmed | Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells |
| title_short | Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells |
| title_sort | inhibition of the na glucose transporter sglt2 reduces glucose uptake and ifnγ release from activated human cd4 t cells |
| topic | glucose uptake T cells SGLT2 GLUT1 immunomodulation IFNγ |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1576216/full |
| work_keys_str_mv | AT zhejin inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT haymahammoud inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT amolkbhandage inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT stasinikoreli inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT azazulislamchowdhury inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT peterbergsten inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells AT bryndisbirnir inhibitionofthenaglucosetransportersglt2reducesglucoseuptakeandifngreleasefromactivatedhumancd4tcells |